Doctors break it down.

South Korean researchers have shown a stem-cell-based topical solution can regrow hair in both male and female subjects with common pattern baldness. The small, randomized, placebo-controlled trial ...

Both studies reached statistically significant endpoints in TAHC (Target-Area Hair Count), with one reaching 539% relative improvement to placebo and the second study reaching 168% relative ...

Losing locks? Don’t wig out just yet. Scientists may have found a hair loss treatment that works better than the top drugs already on the market. The key is that it’s not one drug but three — and it ...

Minoxidil is one of the most widely used, FDA-approved hair loss treatments on the market. It’s used by millions of people all around the world to help fight against hair loss and stimulate new hair ...

Highly statistically significant results at the primary endpoint - statistical significance seen as early as Day 29 Highly statistically significant results on all secondary efficacy endpoints ...

When it comes to the most effective hair retention strategies, few things hold a candle to the two most common treatments: minoxidil and finasteride. (A fancy laser cap helps a ton, too.) And until ...

Clindamycin (as phosphate) 1%. Clindamycin inhibits bacterial protein synthesis by binding to the 23S RNA of the 50S subunit of the ribosome. Clindamycin is predominantly bacteriostatic. Although ...

Seborrheic keratosis is the most common noncancerous skin growth in adults seen by doctors in everyday practice. While it can look like skin cancer, seborrheic keratosis is not thought to be caused by ...